Get the Stockscreener App
0.9095
17.32%
-0.1905
After Hours:
.87
-0.0395
-4.34%
Profusa Inc stock is traded at $0.9095, with a volume of 7.46M.
It is down -17.32% in the last 24 hours and up +0.00% over the past month.
Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
See More
Previous Close:
$1.10
Open:
$1.27
24h Volume:
7.46M
Relative Volume:
41.17
Market Cap:
$29.61M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.8501
$1.33
1-Week Range:
$0.8501
$1.48
52-Week Range:
$0.8501
$1.48
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.9095 | 66.56M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Profusa Inc Stock (PFSA) Latest News
Bitcoin News Today: Profusa Invests $100 Million in Bitcoin to Hedge Inflation - AInvest
Bitcoin News Today: Profusa Secures $100 Million for Bitcoin Treasury Strategy - AInvest
Profusa, Inc. announced that it expects to receive $100 million in funding from Ascent Partners Fund LLC - MarketScreener
Strategy, Trump Media, Sequans, Blockchain Group, and Profusa scoop $2.9B BTC off the market - CryptoRank
Profusa to initiate $100 million bitcoin treasury strategy - Investing.com
Profusa, Inc. Launches $100 Million Bitcoin Treasury Strategy to Enhance Shareholder Value - Quiver Quantitative
Bitcoin News Today: Profusa Secures $100 Million Credit Line for Bitcoin Treasury Reserve - AInvest
Profusa secures $100 million credit line to fund Bitcoin treasury strategy - Investing.com
Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy - Stock Titan
Profusa Completes Business Combination with NorthView - TipRanks
Does Profusa Inc (NASDAQ: PFSA) Still Need To Convince Analysts? - Stocksregister
Post-IPO DebtProfusa - Crunchbase
Profusa commences trading on Nasdaq - Medical Buyer
Profusa's Nasdaq Debut: A Pioneering Leap in Digital Health - AInvest
Market Update: Profusa Closes Merger, Firefly Aerospace Files for US IPO, Tariff Dispute Weighs on Equity Futures - AInvest
Space and defense firm Firefly's US IPO filing reveals 2024 revenue growth - MarketScreener
Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq - GlobeNewswire
Digital Health Innovator Profusa Launches on Nasdaq: Revolutionary Biosensor Platform Goes Public - Stock Titan
NorthView Acquisition extends business combination deadline to August 22 By Investing.com - Investing.com India
NMP Acquisition Prices IPO - MarketScreener
NorthView Acquisition Corp SEC 10-Q Report - TradingView
Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029 - GlobeNewswire
NorthView Acquisition Corp announces stock purchase By Investing.com - Investing.com Nigeria
NorthView Acquisition Corp announces stock purchase - Investing.com
Ultra High Point Holdings Ltd Files For U.S. IPO Of Up To 2.2 Million Ordinary SharesSEC Filing - MarketScreener
NorthView Acquisition Corp SEC 10-K Report - TradingView
EQT has sold Waystar shares for $ 393 million - MarketScreener
NorthView (NVAC) Faces Nasdaq Delisting, Shifts to OTC Market While Pursuing Profusa Merger Deal - Stock Titan
NorthView Acquisition Corporation Announces Exception Granted by Nasdaq to Permit to The Company to Regain Compliance with Listing Rules - Stock Titan
NorthView Acquisition Files Amended Proxy on Profusa Deal - The SPAC Conference
NorthView Acquisition Asking Shareholders for Another 6 Months to Complete Profusa Deal - The SPAC Conference
NorthView Acquisition Files Investor Presentation on $416M Profusa Deal - The SPAC Conference
Lordstown Motors gets Nasdaq delisting notice - MarketScreener
Sidley Represents Profusa, Inc. in Merger with SPAC NorthView Acquisition Corp. - Sidley Austin LLP
NorthView Acquisition Corp. (NVAC) to Combine with Profusa in $416M Deal - SPACInsider
Health Sensors Misconstrued as Government Tracking ‘Microchips’ - FactCheck.org
Fact Check: Military-funded sensor can help detect COVID-19, but it's not a microchip - USA Today
Biodegradable oxygen biosensors via electrospinningCybyk2021MEDICAL DEVICES & SENSORS - Wiley Online Library
A Military-Funded Biosensor Could Be the Future of Pandemic Detection - Defense One
Health + Tech | Implantable devices and healthcare management - Jamaica Gleaner
Injectable oxygen sensor could improve monitoring for peripheral artery disease - National Institutes of Health (NIH) | (.gov)
AFRL partnership advancing wearable sensor technology - wpafb.af.mil
Military wearable computing hits the mainstream - Military Aerospace
Jelly implant keeps an eye on body oxygen levels - Chemistry World
Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality - PR Newswire
Injectable Phosphorescence-based Oxygen Biosensors Identify Post Ischemic Reactive Hyperoxia - Nature
Profusa's Implantable Biosensor Technology Receives $7.5M Boost From DARPA - Med Device Online
Profusa Unveils Biointegrated Sensors for Long-term Continuous Body Chemistry Monitoring - Diagnostic and Interventional Cardiology
Profusa Inc Stock (PFSA) Financials Data
There is no financial data for Profusa Inc (PFSA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.15%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):